Researchers have developed a new computational approach that uncovers possible drugs for specific cellular targets for treating glioblastoma, a lethal brain tumor. This approach enabled them to predict more effective treatment combinations to fight the disease on an individualized basis.

This laboratory and computational research effort was led by scientists at Georgetown’s Lombardi Comprehensive Cancer Center.

“The cellular targets we identified could be key to effectively fighting a disease that has seen only one new targeted drug approved in the last two decades,” says Nagi G. Ayad, Ph.D., senior author, associate director for translational research, and professor of oncology at Georgetown Lombardi.